2022 annual financial data
Ovid Therapeutics 2022 Financial results
Direct answer
Revenue was 1,502,748 USD.
Operating income was -55,548,161 USD and net income was -51,408,292 USD.
Operating cash flow was -55,227,127 USD.
Get free Ovid Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,502,748 USD
- Operating income
- -55,548,161 USD
- Net income
- -51,408,292 USD
- Operating cash flow
- -55,227,127 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Ovid Therapeutics financial years